| scholarly article | Q13442814 |
| P50 | author | Marie Jeansson | Q51804803 |
| Gavin I Welsh | Q56862920 | ||
| Ingeborg Hers | Q57337371 | ||
| Lorna J Hale | Q60061966 | ||
| Samantha F Moore | Q61148267 | ||
| Claire M Perks | Q61993753 | ||
| P2093 | author name string | J M Holly | |
| P W Mathieson | |||
| M A Saleem | |||
| A J Murphy | |||
| J A Hurcombe | |||
| R J Coward | |||
| S N Hardouin | |||
| P2860 | cites work | Angiopoietin-1 is essential in mouse vasculature during development and in response to injury | Q24629743 |
| Molecular and cellular aspects of the insulin-like growth factor I receptor | Q28288023 | ||
| The relationship between proteinuria and coronary risk: a systematic review and meta-analysis | Q33378672 | ||
| Signalling through IGF-I and insulin receptors: where is the specificity? | Q34783548 | ||
| The mesangial cell revisited: no cell is an island | Q34983116 | ||
| Cell biology of the glomerular podocyte | Q35035937 | ||
| HIV-associated renal disorders: recent insights into pathogenesis and treatment. | Q36223895 | ||
| Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action | Q36254770 | ||
| The role of insulin-like growth factor binding proteins. | Q36626462 | ||
| Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells | Q36924959 | ||
| Therapeutic targets in focal and segmental glomerulosclerosis | Q37228164 | ||
| Podocyte loss and progressive glomerular injury in type II diabetes | Q37362675 | ||
| The podocyte cytoskeleton--key to a functioning glomerulus in health and disease | Q37949258 | ||
| The insulin-like growth factor system in kidney disease and hypertension. | Q37962116 | ||
| Biology and significance of signalling pathways activated by IGF-II. | Q37963987 | ||
| Expression and localization of insulin-like growth factor binding proteins in normal and proteinuric kidney glomeruli | Q38339676 | ||
| Establishment of conditionally immortalized human glomerular mesangial cells in culture, with unique migratory properties. | Q39038233 | ||
| Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells | Q39759936 | ||
| Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines | Q39889648 | ||
| Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. | Q40300487 | ||
| The human glomerular podocyte is a novel target for insulin action | Q40357961 | ||
| Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling | Q40851705 | ||
| Beck-Wiedemann syndrome and Wilms' tumour. | Q41547507 | ||
| Insulin signaling to the glomerular podocyte is critical for normal kidney function | Q42110064 | ||
| Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function | Q43264426 | ||
| Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. | Q45060671 | ||
| Targeted gene knockdown in zebrafish reveals distinct intraembryonic functions for insulin-like growth factor II signaling. | Q46011427 | ||
| Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. | Q46393310 | ||
| Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis | Q47647078 | ||
| Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. | Q51531177 | ||
| The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness | Q51609674 | ||
| Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. | Q52027611 | ||
| Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. | Q53661064 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Insulin-like growth factors and cancer | Q56336667 | ||
| Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat | Q57740883 | ||
| Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease | Q58177773 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 95-106 | |
| P577 | publication date | 2013-03-21 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse | |
| P478 | volume | 230 |
| Q91968184 | Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways |
| Q91991368 | Expression of Glutamate Receptor Subtype 3 Is Epigenetically Regulated in Podocytes under Diabetic Conditions |
| Q35086477 | Glomerular endothelial cell injury and cross talk in diabetic kidney disease |
| Q41827044 | Insulin directly stimulates VEGF-A production in the glomerular podocyte |
| Q35285585 | Insulin signaling: implications for podocyte biology in diabetic kidney disease |
| Q49159738 | New insights into mechanisms of glomerular injury and repair from the 10th International Podocyte Conference 2014. |
| Q26766118 | Podocytes |
| Q33821237 | Podocytes, signaling pathways, and vascular factors in diabetic kidney disease |
| Q47885313 | Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor. |
| Q26743407 | Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis |
| Q38176169 | Signal transduction in podocytes--spotlight on receptor tyrosine kinases |
Search more.